MYC and mucopolysaccharidosis type 3D: Our lab has previously shown that myc-tagged recombinant human alpha-N-acetylglucosamine-6-sulfatase (myc-rhGNS) ERT works as a treatment for newborn MPS IIID mice in a single-dose, proof-of-concept study [6].